Passage Bio, Inc. (PASG)
NASDAQ: PASG · Real-Time Price · USD
7.83
-0.02 (-0.25%)
Apr 1, 2026, 10:20 AM EDT - Market open
Passage Bio Employees
Passage Bio had 24 employees as of December 31, 2025. The number of employees decreased by 36 or -60.00% compared to the previous year.
Employees
24
Change (1Y)
-36
Growth (1Y)
-60.00%
Revenue / Employee
n/a
Profits / Employee
-$1,896,750
Market Cap
25.12M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 24 | -36 | -60.00% |
| Dec 31, 2024 | 60 | 2 | 3.45% |
| Dec 31, 2023 | 58 | -27 | -31.76% |
| Dec 31, 2022 | 85 | -48 | -36.09% |
| Dec 31, 2021 | 133 | 59 | 79.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Vistagen Therapeutics | 59 |
| Senti Biosciences | 34 |
| Curis | 34 |
| Cue Biopharma | 29 |
| Tempest Therapeutics | 21 |
| Outlook Therapeutics | 17 |
| Skye Bioscience | 12 |
| Neuphoria Therapeutics | 8 |
PASG News
- 4 weeks ago - Passage Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 5 weeks ago - Passage Bio to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Passage Bio Reports Third Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 5 months ago - Passage Bio to Present at Guggenheim Securities 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 6 months ago - Passage Bio to Participate in Chardan's 9th Annual Genetic Medicines Conference - GlobeNewsWire
- 7 months ago - Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 8 months ago - Passage Bio Reports Second Quarter 2025 Financial Results and Provides Recent Business Highlights - GlobeNewsWire
- 9 months ago - Passage Bio Announces 1-for-20 Reverse Stock Split - GlobeNewsWire